Antibody-Drug Conjugates for Multiple Myeloma — An Interview with Dr Douglas W Sborov (Companion Faculty Lecture)

Research To Practice | Oncology Videos · Sep 23, 2026 · 23m

Featuring a slide presentation and related discussion from Dr Douglas W Sborov, including the following topics:

Overview of the treatment landscape for early relapsed multiple myeloma (MM) (0:00)

Belantamab mafodotin (belamaf) mechanism of action and Phase II DREAMM-2 study of belamaf monotherapy in heavily pretreated MM (6:20)

DREAMM-7 and DREAMM-8 Phase III trials of belamaf combination strategies in patients with MM in the second- and later-line settings (9:20)

Monitoring for and management of belamaf-related ocular toxicities (12:29)

Phase I DREAMM-9 trial of belamaf in combination with…